Zahra Malakoutikhah

University of California System — United States

Medicine · Health Sciences

4h-index85citations36works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cytokine Signaling Pathways and Interactions(20), Nonmelanoma Skin Cancer Studies(3), Asthma and respiratory diseases(2), Cutaneous Melanoma Detection and Management(2), Immune Cell Function and Interaction(2)

Publications36 total

Single-cell transcriptomics reveals immune remodeling of the murine lung microenvironment following chronic house dust mite exposure
Frontiers in Immunology·2025· 1 citedOpen Access
Efficient Workflows for Quantifying Tumor Growth on H&E‐Stained Digital Sections in Mouse Models of Lung Cancer
Current Protocols·2025· 1 cited
Supplementary Figure S8 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S9 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S7 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S14 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S12 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S4 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S6 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S2 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S15 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S3 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S11 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S10 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S1 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S17 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S16 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S13 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Table S2 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S5 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
page 1 of 2Next →

Frequent Co-authors

Samuel Bertin(25), Miki Yamada‐Hara(23), Naoki Takahashi(23), Ji Won Byun(23), Zhihe Wang(23), Han Chang(23), Scott Herdman(23), Maripat Corr(23), Lauren Amaya(22), Sunandini Sharma(22), Arisachi Tanaka(22), Liping Zeng(22), Sneha Ganguly(22), Minh-Chau Vu(22), Matt Levin(22), David Schwartz(22), Jack Heath(22), Eyal Raz(22), Fatemeh Mohaghegh(3), Liping Zeng(3)